Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5981936 | 0.80 | ALDH1A1 (0.50) | HTTKDM4EMAPK1ATMALDH1A1 | |
| SCHEMBL7837631 | 0.75 | KDM4E (0.42) | HTTKDM4EMAPK1HPGDL3MBTL1 | |
| SCHEMBL28805042 | 0.73 | MAPT (0.37) | HTTMAPK1POLBALDH1A1TP53 | |
| SCHEMBL11625717 | 0.73 | POLB (0.50) | HTTPOLBSMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL5982661 | 0.73 | BACE1 (0.40) | HTTKDM4EALDH1A1MAPTKMT2A | |
| SCHEMBL1168424 | 0.71 | ABCG2 (0.35) | MAPK1HPGDATMALDH1A1NPC1 | |
| SCHEMBL1409026 | 0.71 | NPC1 (0.40) | HTTKDM4EMAPK1HPGDPOLB | |
| SCHEMBL1168425 | 0.71 | NPC1 (0.37) | HTTKDM4EHPGDATMALDH1A1 | |
| SCHEMBL1695845 | 0.71 | CYP19A1 (0.38) | KDM4EMAPK1HPGDATMPOLB | |
| SCHEMBL810754 | 0.70 | KDM4E (0.37) | KDM4EHPGDALDH1A1RAB9AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-13 | — | — | US | claimed |
| WO-2024117767-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-06-06 | — | — | WO | claimed |
| CN-114478496-B | Organic compound containing triazine structure and application thereof | 江苏三月科技股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117242066-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-12-15 | — | — | CN | claimed |
| CN-112876486-B | Organic compound, electronic element comprising same and electronic device | 陕西莱特迈思光电材料有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-115745964-A | Organic compound and application thereof | 上海天马微电子有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115368390-A | Single-boron organic compound as OLED (organic light emitting diode) doping material and organic electroluminescent device comprising same | 江苏三月科技股份有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-114621216-A | Organic compound containing triazine structure and organic electroluminescent device | 江苏三月科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114478496-A | Organic compound containing triazine structure and application thereof | 江苏三月科技股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-108117548-B | Spirofluorene compound, application thereof, thermal activation delayed fluorescence material and organic electroluminescent device using spirofluorene compound | 北京鼎材科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| WO-2010094378-A1 | ORGANIC ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| CN-101635334-A | Red organic electroluminescence device and preparation method thereof | UNIV ELECTRONIC SCIENCE & TECH | 2010-01-27 | — | — | CN | claimed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | claimed |
| CN-100555703-C | Luminescent device with quantum efficiency of increase | KONINKL PHILIPS ELECTRONICS NV (NL) | 2009-10-28 | — | — | CN | claimed |
| WO-2009124627-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2009-10-15 | — | — | WO | claimed |
| CN-101426778-A | N-substituted-azacyclylamines as histamine-3 antagonists | WYETH CORP (US) | 2009-05-06 | — | — | CN | claimed |
| CN-101107725-A | Phenothiazines, -s-oxides, and s,s-dioxides as well as phenoxazines as emitters for oleds | BASF AG (DE) | 2008-01-16 | — | — | CN | claimed |
| EP-1817806-A1 | PHENOTHAZINES, -S-OXIDES, AND S,S-DIOXIDES AS WELL AS PHENOXAZINES AS EMITTERS FOR OLEDS | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-15 | — | — | EP | claimed |
| CN-1871723-A | Light-emitting device with increased quantum efficiency | KONINKL PHILIPS ELECTRONICS NV (NL) | 2006-11-29 | — | — | CN | claimed |
| WO-2006056465-A1 | PHENOTHIAZINES, -S-OXIDES, AND S,S-DIOXIDES AS WELL AS PHENOXAZINES AS EMITTERS FOR OLEDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | HTT 971/4885KDM4E 1913/4885MAPK1 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.